LEB1_BOMMO
ID LEB1_BOMMO Reviewed; 179 AA.
AC P54684;
DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-1996, sequence version 1.
DT 25-MAY-2022, entry version 75.
DE RecName: Full=Lebocin-1/2;
DE Flags: Precursor;
OS Bombyx mori (Silk moth).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Bombycoidea;
OC Bombycidae; Bombycinae; Bombyx.
OX NCBI_TaxID=7091;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC STRAIN=Tokai X Asahi; TISSUE=Fat body;
RX PubMed=7545395; DOI=10.1006/bbrc.1995.2284;
RA Chowdhury S., Taniai K., Hara S., Kadono-Okuda K., Kato Y., Yamamoto M.,
RA Xu J., Choi S.K., Debnath N.C., Choi H.K., Miyanoshita A., Sugiyama M.,
RA Asaoka A., Yamakawa M.;
RT "cDNA cloning and gene expression of lebocin, a novel member of
RT antibacterial peptides from the silkworm, Bombyx mori.";
RL Biochem. Biophys. Res. Commun. 214:271-278(1995).
RN [2]
RP PROTEIN SEQUENCE OF 121-152, AND GLYCOSYLATION AT THR-135.
RC TISSUE=Hemolymph;
RX PubMed=7654207; DOI=10.1042/bj3100651;
RA Hara S., Yamakawa M.;
RT "A novel antibacterial peptide family isolated from the silkworm, Bombyx
RT mori.";
RL Biochem. J. 310:651-656(1995).
CC -!- FUNCTION: Antibacterial peptide.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- TISSUE SPECIFICITY: Hemolymph. Produced in fat body.
CC -!- INDUCTION: By bacterial infection.
CC -!- PTM: O-glycosylation is important for the antibacterial activity of
CC lebocin, O-linked glycan structure is a disaccharide (Gal-GalNAc) in
CC case of lebocin 1 and a monosaccharide (GalNAc) in case of lebocin 2.
CC {ECO:0000269|PubMed:7654207}.
CC -!- SIMILARITY: Belongs to the lebocin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; S79612; AAB35218.1; -; mRNA.
DR PIR; JC4247; JC4247.
DR RefSeq; NP_001037468.1; NM_001044003.1.
DR AlphaFoldDB; P54684; -.
DR SMR; P54684; -.
DR TCDB; 1.C.117.1.1; the antibacterial peptide lebocin (lebocin) family.
DR iPTMnet; P54684; -.
DR HOGENOM; CLU_128921_0_0_1; -.
DR Proteomes; UP000005204; Unassembled WGS sequence.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Antibiotic; Antimicrobial; Direct protein sequencing; Glycoprotein;
KW Immunity; Innate immunity; Reference proteome; Secreted; Signal.
FT SIGNAL 1..16
FT /evidence="ECO:0000255"
FT PROPEP 17..120
FT /evidence="ECO:0000255"
FT /id="PRO_0000004974"
FT PEPTIDE 121..152
FT /note="Lebocin-1/2"
FT /id="PRO_0000004975"
FT PROPEP 153..179
FT /evidence="ECO:0000255"
FT /id="PRO_0000004976"
FT REGION 93..116
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 96..116
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 135
FT /note="O-linked (GalNAc...) threonine"
FT /evidence="ECO:0000269|PubMed:7654207"
SQ SEQUENCE 179 AA; 20955 MW; 6B45896B4A4952F1 CRC64;
MYKFLVFSSV LVLFFAQASC QRFIQPTFRP PPTQRPIIRT ARQAGQEPLW LYQGDNVPRA
PSTADHPILP SKIDDVQLDP NRRYVRSVTN PENNEASIEH SHHTVDTGLD QPIESHRNTR
DLRFLYPRGK LPVPTPPPFN PKPIYIDMGN RYRRHASDDQ EELRQYNEHF LIPRDIFQE